Document is current
Any future updates will be listed below
-
Authors
Anderson, Peter https://orcid.org/0000-0002-2171-8228
Austin, Jenny
Elrayes, Mohamed
Rai, Soniya
Ince, Soydan
Alaithan, Mufaddal
Al-Breiki, Fatimah
Steinhoff, Martin
Fatani, Mohammed
Bülbül Başkan, Emel
Al-Lafi, Atlal
Piercy, James
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 9 April 2026
Accepted: 30 June 2026
First Online: 23 July 2026
Declarations
Conflicts of Interest: Peter Anderson, Jenny Austin and James Piercy are employees of Adelphi Real World. Mohamed Elrayes, Soniya Rai, Soydan Ince and Mufaddal Alaithan are employees and shareholders of Eli Lilly and Company. Martin Steinhoff has served on advisory boards for AbbVie, Janssen, Sanofi/Regeneron, Pfizer, Eli Lilly, Galderma, Leo, MenloTx, Novartis, Union Tx, as consultant/speaker for AbbVie, Amgen, Novartis, Janssen, Pfizer, Eli Lilly, Sanofi/Regenereon, Maruho, MenloTx, Union Tx, Galderma, Leo, and has received research funding from Galderma, AbbVie, Leo, Pfizer, Novartis, Sanofi, Genetech, Maruho, Mitsubishi. Mohammed Fatani has served on the advisory boards for Leo Pharma, AbbVie, Pfizer, and Eli Lilly, and as a paid speaker for Eli Lilly and AbbVie. Emel Bülbül Başkan has served as a speaker for Novartis, Janssen, and Eli Lilly. Atlal Al-Lafi has served on advisory boards and as a speaker for Sanofi, AbbVie, Eli Lilly, NewBridge, GSK, Pfizer, Johnson & Johnson, and Novartis. She has also participated in research and publications in collaboration with AbbVie, Sanofi, and more recently, Eli Lilly. Fatimah Al-Breiki has no conflicts of interest to declare.
Ethical Approval: The DSP fulfils the definition of a market research survey under the EphMRA Code of Conduct and is therefore conducted in accordance with market research, rather than clinical, guidelines. Market research surveys are exempt from requiring institutional review board (IRB) approval; however, the Pearl IRB conducted a methodological review of the atopic dermatitis DSP and provided an exemption (#22-ADRW-154). The DSP was conducted in compliance with the Helsinki Declaration of 1964, and its later amendments. Freely given, specific and informed consent was obtained from each respondent to take part in the DSP and for the processing of their personal data. All data provided by dermatologists and patients were anonymized.
